Switzerland – Healthcare, Regulatory and Reimbursement Landscape

Powered by

All the vital news, analysis, and commentary curated by our industry experts.

GlobalData, the industry analysis specialist, has released its latest report, “Switzerland – Healthcare, Regulatory and Reimbursement Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Switzerland. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Swiss pharmaceutical industry is one of the major industries of the country. In 2020, it amounted to about 27.7% of Switzerland’s total exports, making it the country’s largest exporting industry. In terms of Swiss Francs, the country’s pharmaceutical market increased from CHF5.93B in 2013 to CHF6.84B in 2020. It is estimated to increase at a Compound Annual Growth Rate (CAGR) of 1.9% to CHF7.51B in 2025. In the terms of US dollars, the Swiss pharmaceutical market increased from $6.40B in 2013 to $7.28B in 2020, which is estimated to increase at a CAGR of 1.3% to $7.75B in 2025. High expenditure on pharmaceutical R&D and the presence of major pharmaceutical companies have propelled the growth of the pharmaceutical industry. The medical devices market in Switzerland was valued at $2.27B in 2015, which increased to $2.88B in 2020 at a CAGR of 5%. The market is expected to grow at a CAGR of 3% from $3.18B in 2021 to $3.61B in 2025.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Switzerland, and includes:

An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers

Profiles and SWOT analyses of the major players in the pharmaceutical market: Roche, Pfizer, Novartis, Bayer, and Octapharma.

Profiles and SWOT analyses of the major players in the medical device market: Roche, Abbott, Medtronic, Zimmer Biomet, and Smith-Nephew.

An insightful review of the COVID-19 epidemiology, COVID-19 impact, and developments in healthcare market, healthtech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices

Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure

An overview of the opportunities for and challenges to growth in Switzerland healthcare market

Reasons to Buy

This report will enhance your decision-making capability by allowing you to:

Develop business strategies by understanding the trends shaping and driving Switzerland healthcare market

Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact Switzerland healthcare market in the future

Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance

Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership

Table of Contents

1.Table of Contents

1.1List of Figures

1.2List of Tables

2.Executive Summary

2.1Executive Summary

2.2Key Highlights – Facts about Switzerland Healthcare Market

2.3Key Highlights: Healthcare Startups in Switzerland

2.4Key Events: Switzerland Pharmaceutical News, 2015-2021

2.5Key Events: Switzerland Pharmaceutical Market

2.6Key Events: M&As, VC & PE Deals, Global Pharmaceutical Market, 2019-2020

2.7Key Events: Mergers and Acquisitions

2.8Country Profile, Switzerland, 2020

3.Overview of Pharmaceutical Market

3.1Pharmaceutical Market – Overview

3.2 Pharmaceutical Market – Key Areas for Building a Strong Pharma hub in Switzerland, Vision: 2030

3.3Pharmaceutical Market – Exports

3.4Pharmaceutical Market – Imports

3.5Pharmaceutical Market – Supply Channels, Switzerland

3.6 Pharmaceutical Market – Illegal Import of Medicines, Switzerland

3.7 Pharmaceutical Market – Market Segments

3.8Major Therapeutic Areas, Switzerland

3.9COVID-19 Epidemiology, Switzerland

3.10COVID-19 Impact and Developments, Switzerland

3.11COVID-19 Clinical Trials Landscape, Switzerland

3.12 Pharmaceutical Market – Major Players

4.Overview of Medical Devices Market

4.1Medical Device Market – Overview

4.2Medical Devices Market – Major Players

5.Pharmaceutical and Medical Devices Market – Drivers and Barriers

5.1Drivers

5.2Barriers

6.Deal Analysis

6.1Deal Analysis: Pharmaceutical Market, Switzerland, 2019-2021

6.2 Deal Analysis: Medical Device Market, Switzerland, 2019-2021

7.HealthTech Landscape

7.1HealthTech Landscape, Switzerland

7.2 Adoption of Technology in Healthcare, Switzerland

7.3HealthTech Deals Landscape, Switzerland

7.4 Key HealthTech Deals, Switzerland

7.5 Digital Health Regulations, Switzerland

7.6 HealthTech Landscape: Benefits and Risks, Switzerland

8.Market Access

8.1Overview of Healthcare System, Switzerland

8.2 Drug Reimbursement Process, Switzerland

8.3 Overview of Insurance Providers, Switzerland

8.4 Out-of-Pocket Co-Payments and Safety Nets, Switzerland

8.5Out-of-Pocket Spending and Pharmaceutical Price Index, Switzerland

8.6 Pricing Policies, Switzerland

8.7 Regulatory Landscape, Switzerland

8.7.1 Overview of Regulatory Agencies, Switzerland

8.7.2 Marketing Authorization for Pharmaceutical Products, Switzerland

8.7.3 Marketing Authorization for Generic Medicines, Switzerland

8.7.4 Marketing Authorization for Biosimilars, Switzerland

8.7.5 Marketing Authorization for Medical Devices, Switzerland

8.7.6 Export and Import Regulations, Switzerland

8.7.7 Intellectual Property Rights, Patent, Switzerland

8.7.8 Intellectual Property Rights, Trademark, Switzerland

8.7.9 Clinical Trial Regulation Process, Switzerland

8.7.10 Pharmaceutical Clinical Trials Landscape, Switzerland

8.7.11 Medical Devices Clinical Trials Landscape, Switzerland

8.7.12 Pharmacy License Regulations, Switzerland

8.7.13 Online Pharmacy Regulations, Switzerland

8.7.14Pharmaceutical Advertisement Regulations, Switzerland

8.7.15 Labeling and Packaging Regulations, Switzerland

9.Country Healthcare Landscape

9.1Healthcare Policy Highlights, Switzerland

9.2Healthcare Facilities, Switzerland

9.3Healthcare Parameters, Switzerland

9.4Life Expectancy and Immunization Rate, Switzerland

9.5Environmental Health, Switzerland

9.6Healthcare Personnel, Switzerland

9.7Disease Burden, US Switzerland

9.8Healthcare Expenditure, Switzerland

9.9Healthcare Spending Components and Pharmaceutical Spending, Switzerland

11Trade Associations, Conferences, and Trade Fairs, Switzerland

12Opportunities and Challenges

13Appendix

13.1 Research Methodology

13.1.1 Coverage

13.1.2 Secondary Research

13.1.3 Forecasts

13.2 Bibliography

13.3 About GlobalData

13.4 Contact Us

13.5 Disclaimer

Table

Table 1: Pharmaceutical Distribution Channels, Switzerland, 2019

Table 2: Confiscated Shipments: Trend Over the Last Three Years, Switzerland, 2018-2020

Table 3: Origin of Illegal Imports by Country/Region, Switzerland, 2019-2020

Table 4: Confiscated Shipments by Product Categories, Switzerland, 2019-2020

Table 5: Approved Biosimilars, Switzerland, 2017-2019

Table 6: Market Share of Medicines by Therapeutic Indicator Areas, Switzerland, 2019

Table 7: COVID-19 Indicators (Number of Cases), Switzerland and Global, January 2020-July 2021

Table 8: COVID-19-Related Travel Restrictions, Switzerland, 2020-2021

Table 9: Available COVID-19-Vaccines, Switzerland, 2020-2021

Table 10: Available COVID-19 IVD products, Switzerland, 2020-2021

Table 11: Medical Devices Market, Switzerland, Major Segments ($M), 2020

Table 12: Hospital Supplies Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 13: General Surgery Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 14: Orthopedic Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 15: In vitro Diagnostic Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 16: Wound care Management Devices Market, Switzerland, Revenue ($M) and Market Share (%) of Major Companies, 2020

Table 17: Licensed Digital Health Technologies, Switzerland, 2014-2017

Table 18: List of Most Expensive and Least Expensive Cantons, Switzerland

Table 19: Typical Patient Copayments and Safety Nets, Switzerland, 2016

Table 20: Fee for Marketing Authorization of Pharmaceutical Products, Switzerland, 2018

Table 21: Patent Application Fee, Switzerland, 2019

Table 22: Trademark Application Fee, Switzerland, 2019

Table 23: Clinical Trial Application Fee, Switzerland, 2019

Table 24: Trade Fairs, Switzerland

Figures

Figure 1: Pharmaceutical Market, Switzerland, Revenue ($B and CHF B), 2013-2020

Figure 2: Medical Devices Market, Switzerland, Revenue ($B), 2015-2020

Figure 3: Healthcare Start-Ups in Switzerland, 2020

Figure 4: Country Profile, Switzerland, 2020

Figure 5: Pharmaceutical Market, Switzerland, Revenue ($B), 2011-2020

Figure 6: Pharmaceutical Market, Switzerland, Revenue Forecast ($B), 2021-2025

Figure 7: Key Areas for Building a Strong Pharma Hub, Switzerland, Vision: 2030

Figure 8: Pharmaceutical Exports ($B), Switzerland, 2011-2020

Figure 9: Top Export Partners, Switzerland, 2020

Figure 10: Pharmaceutical Imports ($B), Switzerland, 2011-2020

Figure 11: Top Import Partners, Switzerland, 2020

Figure 12: Pharmaceutical Supply Channel, Switzerland, 2020

Figure 13: Reasons for Gaps in Medicine Supply, Switzerland, 2020

Figure 14: Generic Drugs Usage (% Share by Volume), Switzerland, 2010-2020

Figure 15: Generic Drugs Usage (% Share by Value), Switzerland, 2010-2020

Figure 16: Self-Medication Market, Switzerland, Revenue ($M), 2011-2019

Figure 17: Self-Medication Market by Drug Category, Revenue ($M), Switzerland, 2019

Figure 18: Major Therapeutic Product Categories by Number of Drugs Authorized, Switzerland, 2019

Figure 19: Major Therapeutic Areas by Pharmaceutical Sales ($M), Switzerland, 2018-2020

Figure 20: Market Share of Medicines by Therapeutic Indicator Areas, Switzerland, 2019

Figure 21: COVID-19 (Number of Cases), Switzerland, 2020-2021

Figure 22: COVID-19 (Number of Deaths), Switzerland, 2020-2021

Figure 23: COVID-19 Fiscal Stimulus Timeline, Switzerland, 2020-2021

Figure 24: COVID-19 Vaccine Administration, Number of Vaccines Administered, Switzerland, 2021

Figure 25: Top COVID-19 Markets by Product Categories (Number of Available Marketed Products), Switzerland, 2020-2021

Figure 26: Top COVID-19 IVD Products by Device Class (Number of Available Marketed Products), Switzerland, 2020-2021

Figure 27: COVID-19 Clinical Trials Sponsors by Count, Switzerland, 2020-2021

Figure 28: COVID-19 Clinical Trials Count by Phase, Switzerland, 2020-2021

Figure 29: COVID-19 Clinical Trials Count by Trial Status, Switzerland, 2020-2021

Figure 30: Medical Devices Market, Switzerland, Revenue ($B), 2015-2020

Figure 31: Medical Devices Market, Switzerland, Revenue Forecast ($B), 2021-2025

Figure 32: Medical Devices Market, Switzerland, Major Segments (%), 2020

Figure 33: Hospital Supplies Market, Switzerland, Revenue ($M), 2015-2022

Figure 34: Hospital Supplies Market, Switzerland, Market Share of Major Players (%), 2020

Figure 35: General Surgery Devices Market, Switzerland, Revenue ($M), 2015-2022

Figure 36: General Surgery Devices Market, Switzerland, Market Share of Major Players (%), 2020

Figure 37: Orthopedic Devices Market, Switzerland, Revenue ($M), 2015-2022

Figure 38: Orthopedic Devices Market, Switzerland, Market Share of Major Players (%), 2020

Figure 39: In vitro Diagnostic Devices Market, Switzerland, Revenue ($M), 2015-2022

Figure 40: In vitro Diagnostic Devices Market, Switzerland, Market Share of Major Players (%), 2020

Figure 41: Wound care Management Devices Market, Switzerland, Revenue ($M), 2015-2022

Figure 42: Wound care Management Devices Market, Switzerland, Market Share of Major Players (%), 2020

Figure 43: Diagnostic Market, Switzerland, Revenue ($M), 2015-2020

Figure 44: Diagnostic Market, Switzerland, Revenue Forecast ($M), 2021-2025

Figure 45: Medical Devices Market, Switzerland, Revenue ($B) of Major Companies, 2020

Figure 46: Deal Value and Deal Count, Pharmaceutical Market, Switzerland, 2019-2021

Figure 47: Deal Value and Deal Count, Quarterly, Pharmaceutical Market, Switzerland, 2019-2021

Figure 48: Deal Value and Deal Count, Subtypes, Pharmaceutical Market, Switzerland, 2019-2021

Figure 49: Top Therapy Areas by Deal Value, Pharmaceutical Market, Switzerland, 2019-2021

Figure 50: Top Therapy Areas by Deal Count, Pharmaceutical Market, Switzerland, 2019-2021

Figure 51: Mergers and Acquisitions by Quarter, Pharmaceutical Market, Switzerland, 2019-2021 (by Value and by Number)

Figure 52: Venture Financing by Quarter, Pharmaceutical Market, Switzerland, 2019-2021 (by Value and by Number)

Figure 53: Deal Value and Deal Count, Medical Devices Market, Switzerland, 2019-2021

Figure 54: Deal Value and Deal Count, Subtypes, Medical Devices Market, Switzerland, 2019-2021

Figure 55: Deal Value and Deal Count, Quarterly, Medical Devices Market, Switzerland, 2019-2021

Figure 56: Top Equipment Sectors by Deal Value, Medical Devices Market, Switzerland, 2019-2021

Figure 57: Top Equipment Sectors by Deal Count, Medical Devices Market, Switzerland, 2019-2021

Figure 58: Mergers and Acquisitions by Quarter, Medical Devices Market, Switzerland, 2019-2021 (by Value and by Number)

Figure 59: Venture Financing by Quarter, Medical Devices Market, Switzerland, 2019-2021 (by Value and by Number)

Figure 60: Swiss Digital Health Association Ecosystem, Switzerland, 2020

Figure 61: Industrial Technology Facilities, Switzerland, 2020

Figure 62: Swiss Digital Health Start-Up Map, Switzerland, 2021

Figure 63: Deal Value ($M), HealthTech, Switzerland, 2019-2021

Figure 64: Deal Count (Number of Deals), HealthTech, Switzerland, 2019-2021

Figure 65: Key Health Sector Organizations, Switzerland

Figure 66: Overview of Health System, Switzerland, 2020

Figure 67: Reimbursement Process, Switzerland, 2015

Figure 68: Out-of-Pocket Spending ($ per Capita), Switzerland, 2011-2019

Figure 69: Change in Pharmaceutical Price Index (2015 = 100), Switzerland, 2011-2020

Figure 70: Authorized Medicinal Products by Indications, Swissmedic, Switzerland, 2020

Figure 71: Organization Structure, Swissmedic, Switzerland, 2021

Figure 72: Marketing Authorization of Pharmaceutical Products, Swissmedic, Switzerland, 2021

Figure 73: Conformity Assessment of Class I Medical Devices, EU, 2019

Figure 74: Conformity Assessment of Class IIa Medical Devices, EU, 2019

Figure 75: Conformity Assessment of Class IIb Medical Devices, EU, 2019

Figure 76: Conformity Assessment of Class III Medical Devices, EU, 2019

Figure 77: Patent Approval Process, Switzerland, 2019

Figure 78: Trademark Registration Process, Switzerland, 2019

Figure 79: Clinical Trial Approval Process, Switzerland, 2018

Figure 80: Pharmaceutical Clinical Trials Count by Trial Status, Switzerland, 2020-2021

Figure 81: Pharmaceutical Clinical Trials Count by Indication, Switzerland, 2020-2021

Figure 82: Pharmaceutical Clinical Trials Count by Phase, Switzerland, 2020-2021

Figure 83: Top Five Pharmaceutical Clinical Trials Sponsors by Count, Switzerland, 2020-2021

Figure 84: Medical Devices Clinical Trials Count by Trial Status, Switzerland, 2020-2021

Figure 85: Medical Devices Clinical Trials Count by Device Category, Switzerland, 2020-2021

Figure 86: Medical Devices Clinical Trials Count by Indication, Switzerland, 2020-2021

Figure 87: Top Five Medical Devices Clinical Trials Sponsors by Count, Switzerland, 2020-2021

Figure 88: Number of Hospitals, Switzerland, 2012-2020

Figure 89: Number of Diagnostic Equipment, Switzerland, 2015-2020

Figure 90: Number of Acute Care Beds (per 1,000 Population), Switzerland, 2013-2020

Figure 91: Number of Hospital Beds (per 1,000 Population), Switzerland, 2013-2020

Figure 92: Number of Psychiatric Care Beds (per 1,000 Population), Switzerland, 2013-2020

Figure 93: Immunization Rate (% of Children Ages 12-23 Months), Switzerland, 2013-2019

Figure 94: Life Expectancy at Birth (Years), Switzerland, 2013-2019

Figure 95: CO2 Emissions (Million Tons), Switzerland, 2012-2020

Figure 96: PM2.5 (µg per m3), Switzerland, 2012-2020

Figure 97: Physicians (per 1,000 Population), Switzerland, 2012-2020

Figure 98: Pharmacists (per 1,000 Population), Switzerland, 2012-2020

Figure 99: Dentists (per 1,000 Population), Switzerland, 2012-2020

Figure 100: Nurses (per 1,000 Population), Switzerland, 2012-2020

Figure 101: Major Causes of Mortality (per 100,000 population), Switzerland, 2019

Figure 102: Major Causes of Male Mortality (per 100,000 population), Switzerland 2019

Figure 103: Major Causes of Female Mortality (per 100,000 population), Switzerland, 2019

Figure 104: Disability-Adjusted Life Years by Major Disease (per 100,000 population), Switzerland, 2019

Figure 105: Healthcare Expenditure as Percentage of GDP (%), Switzerland, 2012-2019

Figure 106: Health Expenditure Share (% of Total Health Spending), Switzerland, 2012-2019

Figure 107: Pharmaceutical Spending ($ per Capita), Switzerland, 2010-2019

Figure 108: Healthcare Expenditure Components by Function (% of Total Health Expenditure), Switzerland, 2019

Figure 109: Opportunities and Challenges

Frequently asked questions

Switzerland – Healthcare, Regulatory and Reimbursement Landscape thematic reports
Currency USD
$1,995

Can be used by individual purchaser only

$5,985

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company


Undecided about purchasing this report?

Enquire Before Buying Request a Free Sample

Get in touch to find out about multi-purchase discounts

reportstore@globaldata.com
Tel +44 20 7947 2745

Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.

Sample Report

Switzerland – Healthcare, Regulatory and Reimbursement Landscape was curated by the best experts in the industry and we are confident about its unique quality. However, we want you to make the most beneficial decision for your business, so we offer free sample pages to help you:

  • Assess the relevance of the report
  • Evaluate the quality of the report
  • Justify the cost

Download your copy of the sample report and make an informed decision about whether the full report will provide you with the insights and information you need.

Below is a sample report to understand what you are buying

See what our customers are saying

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods

Our experience with GlobalData has been very good, from the platform itself to the people. I find that the analysts and the account team have a high level of customer focus and responsiveness and therefore I can always rely on. The platform is more holistic than other providers. It is convenient and almost like a one stop shop. The pricing suite is highly competitive and value for our organisation.

I like reports that inform new segments such as the analysis on generation Z, millennials, the impact of COVID 19 to our banking customers and their new channel habits. Secondly the specialist insight on affluent sector significantly increases our understanding about this group of customers. The combination of those give us depth and breadth of the evolving market.

I’m in the business of answering and helping people make decisions so with the intelligence center I can do that, effectively and efficiently. I can share quickly key insights that answer and satisfy our country stakeholders by giving them many quality studies and primary research about competitive landscape beyond the outlook of our bank. It helps me be seen as an advisory partner and that makes a big difference. A big benefit of our subscription is that no one holds the whole data and because it allows so many people, so many different parts of our organisation have access, it enables all teams to have the same level of knowledge and decision support.

Head of Customer Insight and Research, Standard Chartered

“I know that I can always rely on Globaldata’s work when I’m searching for the right consumer and market insights. I use Globaldata insights to understand the changing market & consumer landscape and help create better taste & wellbeing solutions for our customers in food, beverage and healthcare industries.

Globaldata has the right data and the reports are of very high quality compared to your competitors. Globaldata not only has overall market sizes & consumer insights on food & beverages but also provides insights at the ingredient & flavour level. That is key for B2B companies like Givaudan. This way we understand our customers’ business and also gain insight to our unique industry”

Head of Consumer Sensory Insights, Givaudan

GlobalData provides a great range of information and reports on various sectors that is highly relevant, timely, easy to access and utilise.  The reports and data dashboards help engagement with clients; they provide valuable industry and market insights that can enrich client conversations and can help in the shaping of value propositions. Moreover, using GlobalData products has helped increase my knowledge of the finance sector, the players within it, and the general threats and opportunities.

I find the consumer surveys that are carried out to be extremely beneficial and not something I have seen anywhere else. They provided an insightful view of why and which consumers take (or don’t) particular financial products. This can help shape conversations with clients to ensure they make the right strategic decisions for their business.

One of the challenges I have found is that data in the payments space is often piecemeal. With GD all of the data I need is in one place, but it also comes with additional market reports that provide useful extra context and information. Having the ability to set-up alerts on relevant movements in the industry, be it competitors or customers, and have them emailed directly to me, ensures I get early sight of industry activity and don’t have to search for news.

Senior Account Manager, TSYS
Go even deeper with GlobalData Intelligence Center

Every Company Report we produce is powered by the GlobalData Intelligence Center.

Subscribing to our intelligence platform means you can monitor developments at Switzerland – Healthcare, Regulatory and Reimbursement Landscape in real time.

  • Access a live Switzerland – Healthcare, Regulatory and Reimbursement Landscape dashboard for 12 months, with up-to-the-minute insights.
  • Fuel your decision making with real-time deal coverage and media activity.
  • Turn insights on financials, deals, products and pipelines into powerful agents of commercial advantage.